Call for Applications: DayOne Accelerator Program

How does the program work?

• DayOne Accelerator is a structured, high-impact, 3-month program:
  • Week 1: Kick-off Bootcamp (Basel, in-person)
  • Weeks 2-12: Hybrid accelerator program
  • Program close: Innovation Showcase (Basel, in-person)
  • Post-accelerator extension program (Expert-in-Residence)
  • Post-accelerator funding
  • Be supported all along

Benefits

• Gain unparalleled access to pharma industry experts and key players in the Basel Area
• Develop or refine your pharma-specific value proposition with hands-on mentorship
• Tap into Basel’s world-class life sciences ecosystem – home to global pharma leaders
• Potential to get access to the post-accelerator program including investment from their partners, CHF50k in non-dilutive funding, and 6 months’ office space
• Stay independent: their accelerator is equity-free and fee-free

Who is the program for?

• Digital health, medtech and techbio ventures with solutions for pharma R&D
• Pre-Seed to Series A stage, with less than $10M of dilutive funds raised to date
• Startups aiming to collaborate or partner with pharma companies

Eligibility Criteria

• Individuals and teams from any country may apply to participate in the program. This also applies to individuals and teams that have registered their company with the commercial register or have founded a society.
• Ventures should be developing solutions in digital health, medtech or techbio, with a specific focus on enabling Pharma R&D processes. Examples of solutions include, but are not limited to:
  • AI-aided drug discovery
  • Digital or imaging biomarkers
  • Diagnostics
  • Clinical trials protocol optimization
  • Patient screening & stratification
  • Decentralized clinical trials & remote monitoring

For more information, visit Basel Area Business & Innovation.